Attached files
| file | filename |
|---|---|
| S-1/A - Arno Therapeutics, Inc | v208078_s1a.htm |
| EX-23.2 - Arno Therapeutics, Inc | v208078_ex23-2.htm |
| EX-10.16 - Arno Therapeutics, Inc | v208078_ex10-16.htm |
| EX-10.15 - Arno Therapeutics, Inc | v208078_ex10-15.htm |
Exhibit
23.1
Consent
of Independent Registered Public Accounting Firm
We
consent to the use in this Pre-effective Amendment No. 1 to the Registration
Statement of Arno Therapeutics, Inc. on Form S-1 of our report dated November 8,
2010 (except for Notes 6 and 10 which are dated January 18, 2011), on the
financial statements of Arno Therapeutics, Inc. and to the reference to us under
the heading “Experts” in the prospectus.
/s/ Crowe
Horwath LLP
New York,
New York
January
18, 2011